Potential drug leads for SARS-CoV2 from phytochemicals of Aerva lanata: a Machine Learning approach

被引:2
|
作者
Sherin D.R. [1 ]
Sharanya N. [1 ]
Manojkumar T.K. [1 ]
机构
[1] School of Digital Sciences, Kerala University of Digital Sciences, Innovation and Technology, Thiruvananthapuram
关键词
Aerva lanata; Docking; Machine learning; SARS-CoV-2;
D O I
10.1007/s13337-021-00732-0
中图分类号
学科分类号
摘要
COVID-19 outbreak is the recently reported worldwide pandemic threat. As part of our interventions with machine learning and molecular simulation approaches, we report the inhibitory effect of thirty compounds reported from the sacred plant Aerva lanata. The predicted activity of the screened ligands are comparable with the one of the present medication, hydroxy chloroquine (HCQ), on the main protease (PDB:6YB7) of SARS-CoV-2. Our studies pointed out the effectiveness of the plant with twenty seven compounds having potential activity against the main protease compared to the reference HCQ. The robustness of some of the phytochemicals such as ervoside, which is only present in Aerva lanata computed to have very high anticoronavirus activity. The results are indicative of potential natural antivirus source, which subsidizes in thwarting the invasion of coronavirus into the human body. Many phytochemicals which are computed to be effective towards SARS-CoV-2 in this study are used as drugs for various other diseases. Perhaps these compounds could be attractive for the management of COVID-19, but clinical trials must be performed in order to validate this observation. © 2021, Indian Virological Society.
引用
收藏
页码:757 / 765
页数:8
相关论文
共 50 条
  • [1] Phytochemicals against SARS-CoV as potential drug leads
    Swain, Shasank Sekhar
    Panda, Sujogya Kumar
    Luyten, Walter
    BIOMEDICAL JOURNAL, 2021, 44 (01) : 74 - 85
  • [2] Polypharmacology guided drug repositioning approach for SARS-CoV2
    Jamir, Esther
    Sarma, Himakshi
    Priyadarsinee, Lipsa
    Kiewhuo, Kikrusenuo
    Nagamani, Selvaraman
    Sastry, G. Narahari
    PLOS ONE, 2023, 18 (08):
  • [3] Applying polypharmacology approach for drug repurposing for SARS-CoV2
    Esther Jamir
    Himakshi Sarma
    Lipsa Priyadarsinee
    Selvaraman Nagamani
    Kikrusenuo Kiewhuo
    Anamika Singh Gaur
    Ravindra K Rawal
    Natarajan Arul Murugan
    Venkatesan Subramanian
    G Narahari Sastry
    Journal of Chemical Sciences, 2022, 134
  • [4] Applying polypharmacology approach for drug repurposing for SARS-CoV2
    Jamir, Esther
    Sarma, Himakshi
    Priyadarsinee, Lipsa
    Nagamani, Selvaraman
    Kiewhuo, Kikrusenuo
    Gaur, Anamika Singh
    Rawal, Ravindra K.
    Murugan, Natarajan Arul
    Subramanian, Venkatesan
    Sastry, G. Narahari
    JOURNAL OF CHEMICAL SCIENCES, 2022, 134 (02)
  • [5] Mesenchymal Stromal Cells and their EVs as Potential Leads for SARS-CoV2 Treatment
    Kia, Vahid
    Eshaghi-gorji, Reza
    Mansour, Reyhaneh Nassiri
    Hassannia, Hadi
    Hasanzadeh, Elham
    Gheibi, Mobina
    Mellati, Amir
    Enderami, Seyed Ehsan
    CURRENT STEM CELL RESEARCH & THERAPY, 2023, 18 (01) : 35 - 53
  • [6] A Citywide Approach to SARS-CoV2 Testing
    Broach, John P.
    Lowell, Monica
    Brown, Olga
    Martin, Clayton
    Muller, Michelle
    Shirshac, Jeanne
    Perrone, Domenica
    Smith, Will
    Castiel, Matilde
    Kobayashi, Kimiyoshi J.
    Lapriore, Cheryl M.
    Dickson, Eric W.
    Babu, Kavita M.
    FRONTIERS IN PUBLIC HEALTH, 2021, 9
  • [7] Phytochemicals as potential drug candidates for targeting SARS CoV 2 proteins, an in silico study
    Nag A.
    Banerjee R.
    Chowdhury R.R.
    Krishnapura Venkatesh C.
    VirusDisease, 2021, 32 (1) : 98 - 107
  • [8] Potential therapeutic and pharmacological strategies for SARS-CoV2
    Doaa A. Ghareeb
    Samar R. Saleh
    Mohammed S. Nofal
    Mohamed M. Y. Kaddah
    Salma. F. Hassan
    Inas K. Seif
    Sally A. El-Zahaby
    Shaimaa M. Khedr
    Marwa Y. Kenawy
    Aliaa A. Masoud
    Salma A. Soudi
    Ahmed A. Sobhy
    Jaillan G. Sery
    Miral G. Abd El-Wahab
    Alshimaa A. Abd Elmoneam
    Abdulaziz Mohsen Al-mahallawi
    Maha A. El-Demellawy
    Journal of Pharmaceutical Investigation, 2021, 51 : 281 - 296
  • [9] Potential therapeutic and pharmacological strategies for SARS-CoV2
    Ghareeb, Doaa A.
    Saleh, Samar R.
    Nofal, Mohammed S.
    Kaddah, Mohamed M. Y.
    Hassan, Salma. F.
    Seif, Inas K.
    El-Zahaby, Sally A.
    Khedr, Shaimaa M.
    Kenawy, Marwa Y.
    Masoud, Aliaa A.
    Soudi, Salma A.
    Sobhy, Ahmed A.
    Sery, Jaillan G.
    El-Wahab, Miral G. Abd
    Elmoneam, Alshimaa A. Abd
    Al-mahallawi, Abdulaziz Mohsen
    El-Demellawy, Maha A.
    JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2021, 51 (03) : 281 - 296
  • [10] Cutaneous drug eruption in a patient infected with SARS-CoV2
    Aldea Manrique, B.
    Ramirez Lluch, M.
    Sanchez Bernal, J.
    MEDICINA DE FAMILIA-SEMERGEN, 2020, 46 : 108 - 109